Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
200 participants
INTERVENTIONAL
2019-03-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.
NCT06510946
Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors
NCT04623190
Healthy Heart Score Intervention In the Primary Care Setting
NCT03482427
Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics
NCT06063564
Evaluating Tools for Health Promotion and Disease Prevention
NCT00164658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants receive standard care in cardiac rehabilitation program
No interventions assigned to this group
Knowledge transfer group
Participants receive standard care in cardiac rehabilitation program plus education regarding telomere length
Education regarding telomere length
Teaching concepts of cellular aging and telomere length
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education regarding telomere length
Teaching concepts of cellular aging and telomere length
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Individuals who may not have the mental capacity to understanding the ramifications of risk biomarkers
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western University, Canada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Geoffrey Pickering MD PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. Geoffrey Pickering, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Western Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
London Health Sciences Centre, Western University
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
109209
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.